DFP has been previously used as an experimental agent in neuroscience for its ability to inhibit cholinesterases and induce delayed peripheral neuropathy [46] and as an ophthalmic cholinesterase inhibitor in glaucoma treatment [47,48]. This evidence concerns the gene BCHE and glaucoma.